| 國立臺灣大學 |
1988 |
Lupus Miliaris Disseminatus Faciei:A Case Report
|
葉思伯; Chen, G. T.; Yeh, Hsu-Po; Chen, G. T. |
| 國立成功大學 |
2018-06 |
Lupus myocarditis receiving the rituximab therapy-a monocentric retrospective study
|
Wang;Chrong-Reen;Tsai;Yi-Shan;Li;Wei-Ting |
| 國立成功大學 |
2018 |
Lupus myocarditis receiving the rituximab therapy—a monocentric retrospective study
|
Wang, C.-R.;Tsai, Y.-S.;Li, W.-T. |
| 中山醫學大學 |
2021 |
Lupus nephritis with corticosteroid responsiveness: molecular changes of CD46-mediated type 1 regulatory T cells
|
Tsai, YG; Chien, JW; Chiu, YM; Su, TC; Chiu, PF; Hsiao, KH; Lin, CY |
| 國立臺灣大學 |
1993 |
Lupus Patients with Peripheral Vascular Thrombosis:the Sig Nificance of Measuring Anticardiolipin Antibody
|
Wang, C. R.; Chou, C. C.; 謝貴雄; Chuang, C. Y.; 陳慶餘; Wang, C. R.; Chou, C. C.; Hsieh, Kue Hsiung; Chuang, C. Y.; Chen, Ching-Yu |
| 國立臺灣大學 |
1993 |
Lupus Patients with Peripheral Vascular Thrombosis:the Significance of Measuring Anticar-Diolipin Antibody
|
Wang, C. R.; Chou, C. C.; 謝貴雄; 莊哲彥; 陳慶餘; Wang, C. R.; Chou, C. C.; Hsieh, Kue-Hsiung; Chuang, Che-Yen; Chen, Ching-Yu |
| 國立臺灣大學 |
1993 |
Lupus Patients with Peripheral Vascular Thrombosis:the Significance of Measuring Anticardiolipin Antibody
|
Wang, C. R.; Chou, C. C.; 謝貴雄; 莊哲彥; 陳慶餘; Wang, C. R.; Chou, C. C.; 謝貴雄; 莊哲彥; Chen, Ching-Yu |
| 高雄醫學大學 |
2005 |
Lupus 病人之EBV VCA IgA 高盛行率
|
陳忠仁;林貴香;林世昌;蔡文展;葉宏明;章順仁;盧勝男;劉宏文 ; Chen CJ;Lin KH;Lin SC;Tsai WC;Yen JH;Chang SJ;Lu SN;Liu HW |
| 臺大學術典藏 |
2021-01-27T01:38:16Z |
Lupus-related advanced liver involvement as the initial presentation of systemic lupus erythematosus
|
Lu M.-C.;Li K.-J.;Hsieh S.-C.;Wu C.-H.;Chia-Li Yu; Lu M.-C.; Li K.-J.; Hsieh S.-C.; Wu C.-H.; CHIA-LI YU |
| 臺大學術典藏 |
2021-01-15T02:46:34Z |
Lupus-related advanced liver involvement as the initial presentation of systemic lupus erythematosus
|
Lu M.-C.; Li K.-J.; SONG-CHOU HSIEH; Wu C.-H.; Yu C.-L. |
| 臺大學術典藏 |
2021-02-01T00:49:12Z |
Lupus-related advanced liver involvement as the initial presentation of systemic lupus erythematosus
|
Lu M.-C.; KO-JEN LI; Hsieh S.-C.; Wu C.-H.; Yu C.-L. |
| 臺大學術典藏 |
2022-02-10T06:51:05Z |
Lupus-related advanced liver involvement as the initial presentation of systemic lupus erythematosus
|
Lu, Ming-Chi; KO-JEN LI; Hsieh, Song-Chou; Wu, Cheng-Han; Yu, Chia-Li |
| 國立臺灣大學 |
2006 |
Lupus-related advanced liver involvement as the initial presentation of systemic lupus erythematosus.
|
Lu, MC; Li, KJ; Hsieh, SC; Wu, CH; Yu, CL. |
| 臺大學術典藏 |
2018-09-10T15:17:16Z |
LUR models for particulate matters in the Taipei metropolis with high densities of roads and strong activities of industry, commerce and construction
|
Lee, J.-H. ; Wu, C.-F. ; Hoek, G. ; De Hoogh, K. ; Beelen, R. ; Brunekreef, B. ; Chan, C.-C.; CHANG-FU WU; CHANG-CHUAN CHAN |
| 臺大學術典藏 |
2022-03-24T03:27:18Z |
LUR models for particulate matters in the Taipei metropolis with high densities of roads and strong activities of industry, commerce and construction
|
Lee J.-H.; Wu C.-F.; Hoek G.; de Hoogh K.; Beelen R.; Brunekreef B.; CHANG-CHUAN CHAN |
| 臺大學術典藏 |
2022-03-24T07:01:45Z |
LUR models for particulate matters in the Taipei metropolis with high densities of roads and strong activities of industry, commerce and construction
|
Lee J.-H.; CHANG-FU WU; Hoek G.; de Hoogh K.; Beelen R.; Brunekreef B.; Chan C.-C. |
| 國立成功大學 |
2017-08-17 |
Lurasidone在大白鼠體內藥物動力學與交互作用
|
謝光俞; Hsieh, Kuang-Yu |
| 國立成功大學 |
2001 |
Lure 型非線性系統之 H-Infinity 控制與迴路轉移回復設計與其在水下無人載具之應用
|
黃正能 |
| 國立成功大學 |
2001 |
Lure 型非線性系統之 H-Infinity 控制與迴路轉移回復設計與其在水下無人載具之應用
|
黃正能 |
| 國立成功大學 |
2024-10 |
Luspatercept for non-deletional hemoglobin H disease
|
Yang;Yuan-Ning;Chou;Yen-Yin;Cheng;Chao-Neng |
| 國立臺灣師範大學 |
2014-10-27T15:42:01Z |
Lust and Love in A Farewell to Arms
|
鄭和周 |
| 國立中山大學 |
2009 |
Lust/Caution in IR: Democratizing World Politics
|
L.H.M. Ling;C.C. Hwang;B.Y. Chen |
| 高雄醫學大學 |
2009 |
lutamine 吸入降低內毒素誘發急性肺損傷效應: 探討熱休克蛋72之角色
|
莊逸君;楊瑞成;黃明賢;王東衡;董慧萍;凃巧紋 |
| 臺北醫學大學 |
1992 |
Luteal phase support in IUI and IVF program.
|
曾啟瑞; Tzeng CR |
| 國立臺灣大學 |
2008-12 |
Luteal support for IVF/ICSI cycles with Crinone 8% (90 mg) twice daily results in higher pregnancy rates than with intramuscular progesterone
|
Ho, CH; Chen, SU; Peng, FS; Chang, CY; Yang, YS |
